NASDAQ: OMDAOmada Health Inc Stock
$15.29+0.71 (+4.87%)
Updated May 1, 2026
OMDA Price
$15.29
Fair Value Price
N/A
Market Cap
$900.97M
52 Week Low
$10.28
52 Week High
$28.40
P/E
-43.69x
P/B
3.92x
P/S
2.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$260.21M
Earnings
-$12.78M
Gross Margin
65.7%
Operating Margin
-3.94%
Profit Margin
-4.9%
Debt to Equity
0.33
Operating Cash Flow
$18M
Beta
1.25
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OMDA Overview
Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine OMDA's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
OMDA
Ranked#4 of 45
Ranked#4 of 45
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $6.70 | A | |
| $52.58 | B | |
| $2.99 | B |
Be the first to know about important OMDA news, forecast changes, insider trades & much more!
OMDA News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OMDA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OMDA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OMDA is poor value based on its book value relative to its share price (3.92x), compared to the US Health Information Services industry average (2.9x)
P/B vs Industry Valuation
OMDA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more OMDA due diligence checks available for Premium users.
Valuation
OMDA fair value
Fair Value of OMDA stock based on Discounted Cash Flow (DCF)
Price
$15.29
Fair Value
-$11.26
Undervalued by
235.79%
OMDA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
OMDA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-43.69x
Industry
26.11x
Market
18.84x
OMDA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.92x
Industry
2.9x
OMDA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OMDA's financial health
Profit margin
Revenue
$75.8M
Net Income
$5.2M
Profit Margin
6.8%
OMDA's Earnings (EBIT) of -$10.24M... subscribe to Premium to read more.
Interest Coverage Financials
OMDA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$305.4M
Liabilities
$75.7M
Debt to equity
0.33
OMDA's short-term assets ($272.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OMDA's short-term assets ($272.93M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OMDA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$21.4M
Investing
-$1.3M
Financing
$3.4M
OMDA's operating cash flow ($18.25M)... subscribe to Premium to read more.
Debt Coverage Financials
OMDA vs Health Information Service Stocks
Omada Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.